For the year ending 2025-12-31, UNCY has $49,135K in assets. $18,938K in debts. $29,198K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 29,198 | |||
| Prepaid expenses and other current assets | 7,692 | |||
| Marketable securities | 12,071 | |||
| Total current assets | 48,961 | |||
| Right of use asset, net | 108 | |||
| Subtotal | 138 | |||
| Less accumulated depreciation | 72 | |||
| Property and equipment, net | 66 | |||
| Total assets | 49,135 | |||
| Accounts payable | 383 | |||
| Accrued liabilities | 1,523 | |||
| Warrant liability | 16,915 | |||
| Operating lease liability - current | 117 | |||
| Total current liabilities | 18,938 | |||
| Total liabilities | 18,938 | |||
| Common stock, 0.001 par value per share 400,000,000 shares authorized at december 31, 2024, and december 31, 2025 11,384,236 and 22,114,245 shares issued and outstanding at december 31, 2024, and december 31, 2025, respectively | 22 | |||
| Accumulated other comprehensive loss | -1 | |||
| Additional paid-in capital | 158,001 | |||
| Accumulated deficit | -127,825 | |||
| Total stockholders equity | 30,197 | |||
| Total liabilities and stockholders equity | 49,135 | |||
Unicycive Therapeutics, Inc. (UNCY)
Unicycive Therapeutics, Inc. (UNCY)